Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Risk adjusted net present value: What is the current valuation of Swedish Orphan Biovitrum's Zurase?
Zurase is a recombinant enzyme commercialized by Swedish Orphan Biovitrum, with a leading Pre-Registration program in Gouty Arthritis (Gout). According...